Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Ipratropium bromide, sold under the trade name Atrovent among others, is a type of anticholinergic medication which is applied by different routes: inhaler, nebulizer, or nasal spray, for different reasons.
The analysis highlights Applications, Interactions and Pharmacology as prominent areas in the source structure around Ipratropium bromide.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Ipratropium bromide shows recurring relationship patterns in the source. For example, Ipratropium bromide → BAN, Chemically, Datura, India, Ipratropium, It, Most, USAN Another extracted example is Ipratropium bromide → NZ: Prescription only, UK: POM (Prescription only), US: ℞-only. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
ipratropium effects side used nasal spray include inhaler nebulizer nose asthma medication allergic common bromide action muscarinic headache pregnancy inhalant
TTTA extracted 65 structured relationships around Ipratropium bromide. Examples in this analysis include Ipratropium bromide → 3D model (JSmol) → Interactive image and Ipratropium bromide → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Ipratropium bromide | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Ipratropium bromide | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Ipratropium bromide | ATC code | R01AX03 (WHO) R03BB01 (WHO) | 1.00 | infobox |
| Ipratropium bromide | CAS Number | 22254-24-6 Y | 1.00 | infobox |
| Ipratropium bromide | CAS Number | Ipratropium: 60205-81-4 Y | 1.00 | infobox |
| Ipratropium bromide | ChEBI | CHEBI:46659 | 1.00 | infobox |
| Ipratropium bromide | ChEMBL | ChEMBL2134724 N | 1.00 | infobox |
| Ipratropium bromide | ChemSpider | 10481997 | 1.00 | infobox |
| Ipratropium bromide | CompTox Dashboard (EPA) | DTXSID10860753 DTXSID60858923, DTXSID10860753 | 1.00 | infobox |
| Ipratropium bromide | Drug class | Anticholinergic (muscarinic antagonist) | 1.00 | infobox |
| Ipratropium bromide | DrugBank | DBSALT002739 | 1.00 | infobox |
| Ipratropium bromide | DrugBank | Ipratropium: DB00332 | 1.00 | infobox |
| Ipratropium bromide | Duration of action | 3–5 hours | 1.00 | infobox |
| Ipratropium bromide | ECHA InfoCard | 100.040.779 | 1.00 | infobox |
| Ipratropium bromide | Elimination half-life | 2 hours | 1.00 | infobox |
| Ipratropium bromide | Formula | C20H30BrNO3 | 1.00 | infobox |
| Ipratropium bromide | IUPHAR/BPS | 325 | 1.00 | infobox |
| Ipratropium bromide | KEGG | D02212 | 1.00 | infobox |
| Ipratropium bromide | Legal status | NZ: Prescription only | 1.00 | infobox |
| Ipratropium bromide | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Ipratropium bromide | Legal status | US: ℞-only | 1.00 | infobox |
| Ipratropium bromide | License data | US DailyMed: Ipratropium bromide | 1.00 | infobox |
| Ipratropium bromide | MedlinePlus | a618013 | 1.00 | infobox |
| Ipratropium bromide | Metabolism | Liver | 1.00 | infobox |
| Ipratropium bromide | Molar mass | 412.368 g·mol−1 | 1.00 | infobox |
| Ipratropium bromide | Onset of action | 15–30 minutes | 1.00 | infobox |
| Ipratropium bromide | Pregnancy category | AU: B1 | 1.00 | infobox |
| Ipratropium bromide | Protein binding | 0–9% in vitro | 1.00 | infobox |
| Ipratropium bromide | PubChem CID | 657308 | 1.00 | infobox |
| Ipratropium bromide | Routes of administration | Inhalation, intranasal | 1.00 | infobox |
The concept neighborhoods around Ipratropium bromide bring nearby vocabulary together. In this analysis, examples include Atropine, Ipratropium and Nasal. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Ipratropium bromide, one of the stronger structural bridges in this analysis connects Ipratropium bromide with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Ipratropium bromide to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Applications, Interactions & Pharmacology, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Ipratropium bromide · EN edition · Analysis: TopicsToTalkAbout